SCHEMBL25260320

SCHEMBL25260320

COc1cc(NC=C2C(=O)OC(C)(C)OC2=O)ccc1OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
HSD17B10 Q99714 2/20 0.54
MAPK1 P28482 1/20 0.54
CASP1 P29466 1/20 0.52
CASP7 P55210 1/20 0.52
CTSV O60911 3/20 0.51
CTSL P07711 3/20 0.51
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
RAB9A P51151 1/20 0.47
TSHR P16473 1/20 0.47
SIRT1 Q96EB6 1/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
KDM4E B2RXH2 1/20 0.47
F2 P00734 1/20 0.45
F10 P00742 1/20 0.45
PRSS1 P07477 1/20 0.45
F7 P08709 1/20 0.45
MRGPRX1 Q96LB2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6433972 0.96 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL17181501 0.88 ALDH1A1 (0.59) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL12663537 0.88 ALDH1A1 (0.54) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL374339 0.86 ALDH1A1 (0.67) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL1890489 0.85 ALDH1A1 (0.49) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL6431150 0.85 ALDH1A1 (0.51) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL12003807 0.81 ALDH1A1 (0.67) ALDH1A1HSD17B10MAPK1CTSVCTSL
SCHEMBL5649656 0.80 ALDH1A1 (0.56) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL23887906 0.79 ALDH1A1 (0.74) ALDH1A1HSD17B10MAPK1CASP1CASP7
SCHEMBL20032548 0.78 ALDH1A1 (0.64) ALDH1A1HSD17B10MAPK1CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595245-B2 Inhibitors of MET kinase CELYN THERAPEUTICS, INC. (US) 2026-04-07 US disclosed
EP-4448510-A1 INHIBITORS OF MET KINASE Kinnate Biopharma Inc. (US) 2024-10-23 EP disclosed
CN-118742542-A Inhibitors of MET kinase 金耐特生物制药公司 2024-10-01 CN disclosed
US-20240067626-A1 INHIBITORS OF MET KINASE CELYN THERAPEUTICS, INC. 2024-02-29 US disclosed
US-11753395-B2 Inhibitors of MET kinase KINNATE BIOPHARMA INC. (US) 2023-09-12 US disclosed
US-20230219929-A1 INHIBITORS OF MET KINASE CELYN THERAPEUTICS, INC. 2023-07-13 US disclosed
WO-2023114809-A1 INHIBITORS OF MET KINASE KINNATE BIOPHARMA INC. (US) 2023-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595245-B2 Inhibitors of MET kinase MET, ABL1, ERBB2 ALDH1A1 2585/4885HSD17B10 4291/4885MAPK1 338/4885
US-20230219929-A1 INHIBITORS OF MET KINASE MET, RET, MERTK ALDH1A1 2071/4885HSD17B10 3607/4885MAPK1 555/4885
US-11753395-B2 Inhibitors of MET kinase MET, RET, MERTK ALDH1A1 2071/4885HSD17B10 3607/4885MAPK1 555/4885
US-20240067626-A1 INHIBITORS OF MET KINASE MET, RET, MERTK ALDH1A1 2071/4885HSD17B10 3607/4885MAPK1 555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.